Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis

NCT05107934 is registered in ClinicalTrials.gov with R-Pharm Overseas, Inc. as lead sponsor.

NCT NCT05107934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05107934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis
Lead sponsor
R-Pharm Overseas, Inc.
Phase
Phase 2/3
Overall status
Suspended
Start date
December 31, 2025
Completion date
October 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent pericarditis